Potru, DO, FASAM S, Sprintz, DO, DFASAM M, Barreveld, MD AM, Kohan, MD L. Buprenorphine: Not a silver bullet, and still controversial. J of Opioid Management [Internet]. 2021 Aug. 1 [cited 2024 Nov. 21];17(7):9-10. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/2984